Abstract CT204: High Cytotoxic T-cell or Polymorphonuclear Cell Infiltrates in the Tumor Microenvironment Correlate with Responses to BL8040 Plus Pembrolizumab Combination Therapy in Metastatic Pancreatic Tumors: Scientific Correlates of a Phase II Clinical Trial